Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Hope Rugo MD

Hope S. Rugo MD

Clinical Professor, Department of Medicine (Hematology/Oncology); Director, Breast Oncology Clinical Trials Program, UCSF, San Francisco, California

Recent Contributions to PracticeUpdate:

  1. Triple Negative Breast Cancer Treatment Update: Capecitabine, Immunotherapy and Platinum Salts
  2. Practical Considerations in Integrating HER2 Biosimilars in Clinical Practice
  3. New Data on Managing HER2+ Disease From SABCS 2016

Most Read This Week

Recently Updated